Richard Rawson

Illicit Drug Supply 2022: More potent methamphetamine forms and mixtures of fentanyl, and the “Xines” and “Xenes”

October 25, 2022 | Richard Rawson, PhD

An undeniable fact of the 2022 illegal drug supply is that it is changing rapidly and it is much more lethal. Methamphetamine with far greater purity and potency and fentanyl mixed into “heroin” cocaine and meth, fentanyl pressed into a variety of pill forms, and potent drugs including xylazine (a veterinary tranquilizer) and isotonitazene a potent opioid are now part of the drug landscape.

Learning objectives:

Understand the new street drug supply to provide effective overdose care and treatment.

Illicit Drug Supply 2022: More potent methamphetamine forms and mixtures of fentanyl, and the “Xines” and “Xenes” Read More »

Contingency Management: Essential Treatment Approach for Individuals with Stimulant Use Disorder

October 18, 2022 | Richard Rawson, PhD

Contingency Management (CM) is a powerful behavioral strategy that has repeatedly been demonstrated to reduce stimulant use by individuals with Stimulant Use Disorder. Use of CM outside of the VA has been rare due to regulatory and funding obstacles. However, CM is cited in the 2022 National Drug Plan as a priority treatment to address the treatment needs of individuals with cocaine and methamphetamine use disorder. Delivery of an effective, evidence-based CM protocol that is in compliance with federal guidelines requires careful development of a training and implementation plan. The presenter will present the steps and key components of the CM protocol and implementation plan being used in California in the first large scale implementation of CM outside the VA.

Contingency Management: Essential Treatment Approach for Individuals with Stimulant Use Disorder Read More »